MARKET

OPK

OPK

Opko Health
NASDAQ
1.230
0.000
0.00%
After Hours: 1.220 -0.01 -0.81% 19:57 04/19 EDT
OPEN
1.200
PREV CLOSE
1.230
HIGH
1.242
LOW
1.200
VOLUME
2.67M
TURNOVER
0
52 WEEK HIGH
2.240
52 WEEK LOW
0.8516
MARKET CAP
857.30M
P/E (TTM)
-4.8965
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at OPK last week (0408-0412)?
Weekly Report · 6d ago
Weekly Report: what happened at OPK last week (0401-0405)?
Weekly Report · 04/08 09:14
Opko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug Candidate
TipRanks · 04/03 10:26
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
NASDAQ · 04/01 17:01
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
OPKO Health has an average price target of $2.75. The biotechnology company has a 12-month revenue growth rate of -1.85%. The company's market capitalization is below the average for the Health Care sector. OPKO Health is a diversified company that operates in diagnostics and pharmaceuticals.
Benzinga · 04/01 17:00
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
NASDAQ · 04/01 16:42
OPKO Health Is Maintained at Outperform by Barrington Research
Dow Jones · 04/01 16:26
OPKO Health Price Target Maintained With a $1.50/Share by Barrington Research
Dow Jones · 04/01 16:26
More
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.